uPAR-targeting contrast agents

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8568689
SERIAL NO

11576193

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to contrast agents for detection of the Urokinase Plasminogen Activator Receptor (uPAR). More specifically the invention relates to contrast agents comprising a peptidic vector binding to the uPAR, labelled with an imageable moiety.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GE HEALTHCARE ASNYCOVIEN 1 P O BOX 4220 NYDALEN OSLO 0485

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Arbo, Bente E Nycoveien, NO 3 7
Cuthbertson, Alan Nycoveien, NO 103 1205

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 29, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00